Activation of Akt signaling in rat brain by intracerebroventricular injection of ouabain: A rat model for mania

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 6, 2010, Pages 888-894

  Yu, Hyun Sook ^a,b   Kim, Se Hyun ^a,b   Park, Hong Geun ^a,b   Kim, Yong Sik ^a   Ahn, Yong Min ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Bipolar disorder; Digitalis like compound; GSK 3 ; Na K ATPase

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOGEN SYNTHASE KINASE 3BETA; OUABAIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, RAT; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; NERVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; FRONTAL CORTEX; HIPPOCAMPUS; HYPERACTIVITY; IMMUNOREACTIVITY; LOCOMOTION; MALE; MANIA; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; MOTOR ACTIVITY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FORKHEAD TRANSCRIPTION FACTORS; GLYCOGEN SYNTHASE KINASE 3; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NITRIC OXIDE SYNTHASE TYPE III; OUABAIN; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 78049440126     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.04.010     Document Type: Article

References (83)

1. Accili D., Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004, 117:421-426.
2. Ahn Y.M., Seo M.S., Kim S.H., Kim Y., Yoon S.C., Juhnn Y.S., et al. Increased phosphorylation of Ser473-Akt, Ser9-GSK-3beta and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection. Int J Neuropsychopharmacol 2005, 8:607-613.
3. Aperia A. New roles for an old enzyme: Na, K-ATPase emerges as an interesting drug target. J Intern Med 2007, 261:44-52.
4. Aubry J.M., Schwald M., Ballmann E., Karege F. Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation. Psychopharmacology (Berl) 2009, 205:419-429.
5. Beaulieu J.M., Caron M.G. Looking at lithium: molecular moods and complex behaviour. Mol Interv 2008, 8:230-241.
6. Beaulieu J.M., Tirotta E., Sotnikova T.D., Masri B., Salahpour A., Gainetdinov R.R., et al. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci 2007, 27:881-885.
7. Bredt D.S., Snyder S.H. Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium. Neuron 1994, 13:301-313.
8. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
9. Chalecka-Franaszek E., Chuang D.M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci U S A 1999, 96:8745-8750.
10. Christo P.J., El-Mallakh R.S. Possible role of endogenous ouabain-like compounds in the pathophysiology of bipolar illness. Med Hypotheses 1993, 41:378-383.
11. Cousins D.A., Butts K., Young A.H. The role of dopamine in bipolar disorder. Bipolar Disord 2009, 11:787-806.
12. De Sarno P., Li X., Jope R.S. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 2002, 43:1158-1164.
13. del Peso L., Gonzalez V.M., Hernandez R., Barr F.G., Nunez G. Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt. Oncogene 1999, 18:7328-7333.
14. Dubovsky S.L., Christiano J., Daniell L.C., Franks R.D., Murphy J., Adler L., et al. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch Gen Psychiatry 1989, 46:632-638.
15. Dubovsky S.L., Lee C., Christiano J., Murphy J. Elevated platelet intracellular calcium concentration in bipolar depression. Biol Psychiatry 1991, 29:441-450.
16. Dubovsky S.L., Murphy J., Thomas M., Rademacher J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry 1992, 149:118-120.
17. El-Mallakh R.S., Harrison L.T., Li R., Changaris D.G., Levy R.S. An animal model for mania: preliminary results. Prog Neuropsychopharmacol Biol Psychiatry 1995, 19:955-962.
18. El-Mallakh R.S., El-Masri M.A., Huff M.O., Li X.P., Decker S., Levy R.S. Intracerebroventricular administration of ouabain as a model of mania in rats. Bipolar Disord 2003, 5:362-365.
19. El-Mallakh R.S., Decker S., Morris M., Li X.P., Huff M.O., El-Masri M.A., et al. Efficacy of olanzapine and haloperidol in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1261-1264.
20. Emamghoreishi M., Schlichter L., Li P.P., Parikh S., Sen J., Kamble A., et al. High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry 1997, 154:976-982.
21. Eva A., Kirch U., Scheiner-Bobis G. Signaling pathways involving the sodium pump stimulate NO production in endothelial cells. Biochim Biophys Acta 2006, 1758:1809-1814.
22. Fayard E., Tintignac L.A., Baudry A., Hemmings B.A. Protein kinase B/Akt at a glance. J Cell Sci 2005, 118:5675-5678.
23. Freitas T.P., Scaini G., Correa C., Santos P.M., Ferreira G.K., Rezin G.T., et al. Evaluation of brain creatine kinase activity in an animal model of mania induced by ouabain. J Neural Transm 2010, 117:149-153.
24. Gilley J., Coffer P.J., Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 2003, 162:613-622.
25. Goldstein I., Levy T., Galili D., Ovadia H., Yirmiya R., Rosen H., et al. Involvement of Na(+), K(+)-ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry 2006, 60:491-499.
26. Grider G., El-Mallakh R.S., Huff M.O., Buss T.J.R., Miller J., Valdes R. Endogenous digoxin-like immunoreactive factor (DLIF) serum concentrations are decreased in manic bipolar patients compared to normal controls. J Affect Disord 1999, 54:261-267.
27. Grimes C.A., Jope R.S. CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem 2001, 78:1219-1232.
28. Haas M., Askari A., Xie Z. Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J Biol Chem 2000, 275:27832-27837.
29. Hamid H., Gao Y., Lei Z., Hougland M.T., El-Mallakh R.S. Effect of ouabain on sodium pump alpha-isoform expression in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:1103-1106.
30. Herman L., Hougland T., El-Mallakh R.S. Mimicking human bipolar ion dysregulation models mania in rats. Neurosci Biobehav Rev 2007, 31:874-881.
31. Jornada L.K., Moretti M., Valvassori S.S., Ferreira C.L., Padilha P.T., Arent C.O., et al. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain. J Psychiatr Res 2010, 44:506-510.
32. Kang U.G., Roh M.S., Jung J.R., Shin S.Y., Lee Y.H., Park J.B., et al. Activation of protein kinase B (Akt) signaling after electroconvulsive shock in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:41-44.
33. Khundmiri S.J., Metzler M.A., Ameen M., Amin V., Rane M.J., Delamere N.A. Ouabain induces cell proliferation through calcium-dependent phosphorylation of Akt (protein kinase B) in opossum kidney proximal tubule cells. Am J Physiol Cell Physiol 2006, 291:C1247-C1257.
34. Khundmiri S.J., Amin V., Henson J., Lewis J., Ameen M., Rane M.J., et al. Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proximal tubule cells through an ERK-dependent pathway. Am J Physiol Cell Physiol 2007, 293:C1171-C1180.
35. Kim S.H., Yu H.S., Park H.G., Jeon W.J., Song J.Y., Kang U.G., et al. Dose-dependent effect of intracerebroventricular injection of ouabain on the phosphorylation of the MEK1/2-ERK1/2-p90RSK pathway in the rat brain related to locomotor activity. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1637-1642.
36. Kotova O., Galuska D., Essen-Gustavsson B., Chibalin A.V. Metabolic and signaling events mediated by cardiotonic steroid ouabain in rat skeletal muscle. Cell Mol Biol (Noisy-le-grand) 2006, 52:48-57.
37. Krishnan V., Han M.H., Mazei-Robison M., Iniguez S.D., Ables J.L., Vialou V., et al. AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biol Psychiatry 2008, 64:691-700.
38. Kulikov A., Eva A., Kirch U., Boldyrev A., Scheiner-Bobis G. Ouabain activates signaling pathways associated with cell death in human neuroblastoma. Biochim Biophys Acta 2007, 1768:1691-1702.
39. Li R., El-Mallakh R.S., Harrison L., Changaris D.G., Levy R.S. Lithium prevents ouabain-induced behavioral changes. Toward an animal model for manic depression. Mol Chem Neuropathol 1997, 31:65-72.
40. Liu L., Zhao X., Pierre S.V., Askari A. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes. Am J Physiol Cell Physiol 2007, 293:C1489-C1497.
41. Looney S.W., El-Mallakh R.S. Meta-analysis of erythrocyte Na, K-ATPase activity in bipolar illness. Depress Anxiety 1997, 5:53-65.
42. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
43. McGinty J.F., Shi X.D., Schwendt M., Saylor AToda S. Regulation of psychostimulant-induced signaling and gene expression in the striatum. J Neurochem 2008, 104:1440-1449.
44. Modur V., Nagarajan R., Evers B.M., Milbrandt J. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem 2002, 277:47928-47937.
45. Naylor G.J., MacNamee H.B., Moody J.P. Erythrocyte sodium and potassium in depressive illness. J Psychosom Res 1970, 14:173-177.
46. Naylor G.J., McNamee H.B., Moody J.P. Changes in erythrocyte sodium and potassium on recovery from depressive illness. Br J Psychiatry 1971, 118:219-223.
47. Nesher M., Shpolansky U., Rosen H., Lichtstein D. The digitalis-like steroid hormones: new mechanisms of action and biological significance. Life Sci 2007, 80:2093-2107.
48. Parsa A.T., Holland E.C. Cooperative translational control of gene expression by Ras and Akt in cancer. Trends Mol Med 2004, 10:607-613.
49. Paxinos G., Watson C. The rat brain in stereotactic coordinates 1998, Academic Press, Sydney. 4th ed.
50. Perrine S.A., Miller J.S., Unterwald E.M. Cocaine regulates protein kinase B and glycogen synthase kinase-3 activity in selective regions of rat brain. J Neurochem 2008, 107:570-577.
51. Pietilainen O.P., Paunio T., Loukola A., Tuulio-Henriksson A., Kieseppa T., Thompson P., et al. Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:683-692.
52. Polter A., Yang S., Zmijewska A.A., van Groen T., Paik J.H., Depinho R.A., et al. Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation. Biol Psychiatry 2009, 65:150-159.
53. Reif A., Schmitt A., Fritzen S., Chourbaji S., Bartsch C., Urani A., et al. Differential effect of endothelial nitric oxide synthase (NOS-III) on the regulation of adult neurogenesis and behaviour. Eur J Neurosci 2004, 20:885-895.
54. Reif A., Strobel A., Jacob C.P., Herterich S., Freitag C.M., Topner T., et al. A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder. Int J Neuropsychopharmacol 2006, 9:13-20.
55. Rena G., Guo S., Cichy S.C., Unterman T.G., Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 1999, 274:17179-17183.
56. Riegel R.E., Valvassori S.S., Elias G., Reus G.Z., Steckert A.V., de Souza B., et al. Animal model of mania induced by ouabain: evidence of oxidative stress in submitochondrial particles of the rat brain. Neurochem Int 2009, 55:491-495.
57. Roh M.S., Seo M.S., Kim Y., Kim S.H., Jeon W.J., Ahn Y.M., et al. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex. Exp Mol Med 2007, 39:353-360.
58. Rose A.M., Mellett B.J., Valdes R., Kleinman J.E., Herman M.M., Li R., et al. Alpha 2 isoform of the Na, K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals. Biol Psychiatry 1998, 44:892-897.
59. Roskams A.J., Bredt D.S., Dawson T.M., Ronnett G.V. Nitric oxide mediates the formation of synaptic connections in developing and regenerating olfactory receptor neurons. Neuron 1994, 13:289-299.
60. Ruggero D., Sonenberg N. The Akt of translational control. Oncogene 2005, 24:7426-7434.
61. Ruktanonchai D.J., El-Mallakh R.S., Li R., Levy R.S. Persistent hyperactivity following a single intracerebroventricular dose of ouabain. Physiol Behav 1998, 63:403-406.
62. Schleicher M., Yu J., Murata T., Derakhshan B., Atochin D., Qian L., et al. The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo. Sci Signal 2009, 2:ra41.
63. Schoner W., Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 2007, 293:C509-C536.
64. Seo M.S., Kim S.H., Ahn Y.M., Kim Y., Jeon W.J., Yoon S.C., et al. The effects of repeated administrations of MK-801 on ERK and GSK-3beta signalling pathways in the rat frontal cortex. Int J Neuropsychopharmacol 2007, 10:359-368.
65. Sessa W.C. eNOS at a glance. J Cell Sci 2004, 117:2427-2429.
66. Snyder S.H., Ferris C.D. Novel neurotransmitters and their neuropsychiatric relevance. Am J Psychiatry 2000, 157:1738-1751.
67. Sutton G., Chandler L.J. Activity-dependent NMDA receptor-mediated activation of protein kinase B/Akt in cortical neuronal cultures. J Neurochem 2002, 82:1097-1105.
68. Takaishi H., Konishi H., Matsuzaki H., Ono Y., Shirai Y., Saito N., et al. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc Natl Acad Sci U S A 1999, 96:11836-11841.
69. Tang E.D., Nunez G., Barr F.G., Guan K.L. Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 1999, 274:16741-16746.
70. Thiselton D.L., Vladimirov V.I., Kuo P.H., McClay J., Wormley B., Fanous A., et al. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry 2008, 63:449-457.
71. Tian J., Cai T., Yuan Z., Wang H., Liu L., Haas M., et al. Binding of Src to Na+/K+-ATPase forms a functional signaling complex. Mol Biol Cell 2006, 17:317-326.
72. Tian J., Li X., Liang M., Liu L., Xie J.X., Ye Q., et al. Changes in sodium pump expression dictate the effects of ouabain on cell growth. J Biol Chem 2009, 284:14921-14929.
73. Toyota T., Yamada K., Detera-Wadleigh S.D., Yoshikawa T. Analysis of a cluster of polymorphisms in AKT1 gene in bipolar pedigrees: a family-based association study. Neurosci Lett 2003, 339:5-8.
74. Traub N., Lichtstein D. The mood cycle hypothesis: possible involvement of steroid hormones in mood regulation by means of Na+, K+-ATPase inhibition. J Basic Clin Physiol Pharmacol 2000, 11:375-394.
75. Vogt P.K., Jiang H., Aoki M. Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 2005, 4:908-913.
76. Wada A. Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J Pharmacol Sci 2009, 110:14-28.
77. Wei Y., Williams J.M., Dipace C., Sung U., Javitch J.A., Galli A., et al. Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism. Mol Pharmacol 2007, 71:835-842.
78. Williams J.M., Owens W.A., Turner G.H., Saunders C., Dipace C., Blakely R.D., et al. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol 2007, 5:e274.
79. Xie Z., Cai T. Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv 2003, 3:157-168.
80. Xu B., Wratten N., Charych E.I., Buyske S., Firestein B.L., Brzustowicz L.M. Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder. PLoS Med 2005, 2:e263.
81. Yanik M., Vural H., Tutkun H., Zoroglu S.S., Savas H.A., Herken H., et al. The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci 2004, 254:43-47.
82. Yuan Z., Cai T., Tian J., Ivanov A.V., Giovannucci D.R., Xie Z. Na/K-ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Mol Biol Cell 2005, 16:4034-4045.
83. Zhou X., Jiang G., Zhao A., Bondeva T., Hirszel P., Balla T. Inhibition of Na, K-ATPase activates PI3 kinase and inhibits apoptosis in LLC-PK1 cells. Biochem Biophys Res Commun 2001, 285:46-51.